Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Björklund

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Journal of Parkinson'S Disease|May 3, 2021
GDNF Therapy: Can We Make It Work?Anders Björklund
Novartis Foundation Symposium|July 30, 2005
Cell therapy for Parkinson's disease: problems and prospectsAnders Björklund
Trends in Neurosciences|July 10, 2003
Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectorsDeniz Kirik, Anders Björklund
Autophagy|May 30, 2013
TFEB: Pathogenic role and therapeutic target in Parkinson diseaseMickael Decressac, Anders Björklund
Journal of Parkinson'S Disease|March 12, 2017
Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?Anders Björklund, Olle Lindvall
Journal of Neural Transmission (Vienna, Austria : 1996)|February 27, 2018
The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspectiveManolo Carta, Anders Björklund
Cell Stem Cell|July 4, 2020
From Skin to Brain: A Parkinson's Disease Patient Transplanted with His Own CellsMalin Parmar, Anders Björklund
Journal of Parkinson'S Disease|July 20, 2024
The AAV-α-Synuclein Model of Parkinson's Disease: An UpdateAnders Björklund, Bengt Mattsson
Frontiers in Cellular Neuroscience|June 18, 2020
Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in PerspectiveAnders Björklund, Malin Parmar
Journal of Parkinson'S Disease|August 14, 2013
mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian ratsMickael Decressac, Anders Björklund
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Journal of Parkinson'S Disease|May 3, 2021
GDNF Therapy: Can We Make It Work?Anders Björklund
Novartis Foundation Symposium|July 30, 2005
Cell therapy for Parkinson's disease: problems and prospectsAnders Björklund
Trends in Neurosciences|July 10, 2003
Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectorsDeniz Kirik, Anders Björklund
Autophagy|May 30, 2013
TFEB: Pathogenic role and therapeutic target in Parkinson diseaseMickael Decressac, Anders Björklund
Journal of Parkinson'S Disease|March 12, 2017
Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?Anders Björklund, Olle Lindvall
Journal of Neural Transmission (Vienna, Austria : 1996)|February 27, 2018
The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspectiveManolo Carta, Anders Björklund
Cell Stem Cell|July 4, 2020
From Skin to Brain: A Parkinson's Disease Patient Transplanted with His Own CellsMalin Parmar, Anders Björklund
Journal of Parkinson'S Disease|July 20, 2024
The AAV-α-Synuclein Model of Parkinson's Disease: An UpdateAnders Björklund, Bengt Mattsson
Frontiers in Cellular Neuroscience|June 18, 2020
Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in PerspectiveAnders Björklund, Malin Parmar
Journal of Parkinson'S Disease|August 14, 2013
mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian ratsMickael Decressac, Anders Björklund
Pageof 13